Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease

 -Synuclein Negatively Regulates Protein Kinase C  Expression to Suppress Apoptosis in Dopaminergic Neurons by Reducing p300 Histone Acetyltransferase Activity

(2011) H. Jin et al.   JOURNAL OF NEUROSCIENCE

Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice

(2011) Kari A. Trumbull et al.   NEUROBIOLOGY OF DISEASE

Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease

(2011) Magali Dumont et al.   NEUROSCIENCE LETTERS

Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation

(2010) Daniela Impellizzeri et al.   BIOCHEMICAL PHARMACOLOGY

Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model

(2010) Anamitra Ghosh et al.   FREE RADICAL BIOLOGY AND MEDICINE

Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury

(2010) Daniela Impellizzeri et al.   FREE RADICAL RESEARCH

Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

(2009) A. Ghosh et al.   JOURNAL OF NEUROSCIENCE

Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death

(2008) Yogesh C. Awasthi et al.   FREE RADICAL BIOLOGY AND MEDICINE

Dose Formulation and Analysis of Diapocynin

(2007) Ron Luchtefeld et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo

(2003) Thomas Dehmer et al.   JOURNAL OF NEUROCHEMISTRY